John's appointment as our first independent director also enhances our corporate governance as a public company and advances us toward meeting the qualification for listing on a major exchange, like the Nasdaq Stock Market.
As a physician, health system executive, and former CEO of a software analytics company listed on the NASDAQ, Dr. Paulus brings a unique and valuable perspective to Vocera and our board of directors.
